ArticleScientific reports2025
Structural and conformational rearrangements of human serum albumin, transferrin, and blood plasma induced by carbosilane dendrimer therapeutic delivery system.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Tiered Evaluation of Carbosilane Dendrimer-siRNA Nanoplatform from Single-Cell Biocompatibility to Blood-Brain Barrier Model Dynamics and Murine Alzheimer Model Behavior Assessment.ACS applied materials & interfaces · 2026Article
- Therapeutic strategies for ischemic heart disease with natural product-based nanomedicines.Journal of nanobiotechnology · 2026Review
- Hemocompatibility of Carbosilane Dendrimers as a Therapeutic siRNA Delivery System across Blood-Brain Barrier.ACS applied materials & interfaces · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Upon intravenous administration, nanoparticles quickly become enveloped by plasma proteins, lipids, and sugars, forming a biomolecular corona that redefines their biological identity and directs systemic distribution. In this study, we examine a third-generation, positively charged, PEGylated carbosilane dendrimer engineered for the delivery of therapeutic siRNA across the blood-brain barrier. Employing a comprehensive array of analytical techniques-including fluorescence quenching assays, circular dichroism spectroscopy, isothermal titration calorimetry, atomic force microscopy, and transmission electron microscopy-we characterize the dendrimer's binding kinetics and thermodynamics, and its impact on structure of human serum albumin, transferrin and complex environment of plasma. Our findings reveal that the dendrimer induces distinct conformational rearrangements at both tertiary and secondary levels, with thermodynamic analyses indicating that the interactions are predominantly driven by favorable entropy changes and multivalent binding. Furthermore, the dendrimer appears to promote a reorganization of plasma components, potentially leading to aggregation and misfolding reminiscent of fibril formation. Collectively, these findings provide critical insights into the more profound understanding of nanoparticle-protein interactions affecting the biodistribution and hemocompatibility of nanovectors and lay a foundation for further research aimed at safer and more effective therapeutic applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.